Isbn: 9780443457913 - Gene and Cell Therapies: Principles of Pharmaceutical Development (9 results)

- Softcover
Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
£ 81.41
£ 12.50 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Paperback. Condition: Brand New. 250 pages. 8.50x0.56x10.87 inches. In Stock.

Language: English
Published by Elsevier Science Publishing Co Inc, San Diego, 2026
- Softcover
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail
Contact seller5-star sellerCondition: New
£ 109.62
Free ShippingShips within U.S.A.Quantity: 1 available
Paperback. Condition: new. Paperback. Gene and Cell Therapies Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

- Softcover
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrelandKennys Bookshop and Art Galleries Ltd.
Contact seller5-star sellerCondition: New
£ 115.94
£ 8.15 shippingShips from Ireland to U.S.A.Quantity: 12 available
Condition: New. 2026. paperback. . . . . .

- Softcover
Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
£ 125.85
£ 12.50 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Paperback. Condition: Brand New. 250 pages. 8.50x0.56x10.87 inches. In Stock.

- Softcover
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 99.75
£ 42.01 shippingShips from Germany to U.S.A.Quantity: 2 available
Condition: New. Discusses the concepts behind marketed and future gene and cell therapiesDetails information from the molecular level to manufacturing strategiesIncludes timely and thought provoking material for the student and professional in aca.

- Softcover
Seller: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contact seller5-star sellerCondition: New
£ 142.13
£ 7.85 shippingShips within U.S.A.Quantity: 12 available
Condition: New. 2026. paperback. . . . . . Books ship from the US and Ireland.

Language: English
Published by Elsevier Science Publishing Co Inc, San Diego, 2026
- Softcover
Seller: CitiRetail, Stevenage, United KingdomCitiRetail
Contact seller5-star sellerCondition: New
£ 110.99
£ 37.00 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: new. Paperback. Gene and Cell Therapies Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Language: English
Published by Elsevier Science Publishing Co Inc, San Diego, 2026
- Softcover
Seller: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contact seller5-star sellerCondition: New
£ 168.60
£ 27.68 shippingShips from Australia to U.S.A.Quantity: 1 available
Paperback. Condition: new. Paperback. Gene and Cell Therapies Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 189.44
£ 26.15 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. Neuware - Gene and Cell Therapies: Principles of Pharmaceutical Development explores increasing interest in gene and cell therapies following powerful demonstrations of their capability to treat rare genetic disorders, advanced cancers, and regenerate or repair tissues. Sections cover the design of viral vectors, oncolytic viruses, ribonucleic acid cancer vaccines, and autologous and allogeneic cell therapies, along with impacts on their pharmaceutical development. Advances in molecular and cell biology that have led to efficacious and safe gene and cell therapies are also covered, including their relationship to the process and analytical developments that ensure quality.Gene and Cell Therapies: Principles of Pharmaceutical Development scope and style, along with included case studies, learning points, and lecture slides will allow non-specialists to develop a foundational understanding, while new concepts urge further advancements. Although these new, advanced medicines are continually being improved upon, their complex manufacture remains a key obstacle to increasing patient access. …